CareDx Stock News

AlloCell is a surveillance solution for patients who have received engineered-cell transplants for allogeneic cell therapy. Allogeneic cell therapy is a rapidly growing area of clinical development w

UBS Asset Management Americas Inc. cut its holdings in CareDx Inc (NASDAQ:CDNA) by 12.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 29,770 shares of the c

Nuveen Asset Management LLC lessened its stake in CareDx Inc (NASDAQ:CDNA) by 7.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commissi

CareDx (NASDAQ:CDNA) had its price target decreased by Craig Hallum from $48.00 to $42.00 in a report published on Thursday, The Fly reports. Craig Hallum currently has a buy rating on the stock. Seve

In 2012 Peter Maag was appointed CEO of CareDx, Inc (NASDAQ:CDNA). This report will, first, examine the CEO...

The FDA has signed off on a Phase 2 clinical trial evaluating intranasal administration of Biohaven Pharmaceutical Holding Company's (NYSE:BHVN) migraine med vazegepant, a calcitonin gene-related pept

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 8) Keros Therapeutics Inc (...

CareDx mobilizes 10,000 phlebotomists for home blood draws with RemoTraC CDNA DGX

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CareDx (CDNA) and Molecular Partners AG (MLLCF) with

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CareDx (CDNA

CareDx launched RemoTraC, a new service that provides home blood draws of routine transplant blood tests, on March 16 in response to the COVID-19 pandemic. Transplant patients are immunosuppressed an

In the quarter, the Company provided approximately 15,000 patient results, increasing 50% year-over-year. The preliminary information presented in this press release is based on CareDx’s current ex

Man Group plc purchased a new position in CareDx Inc (NASDAQ:CDNA) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 95,459 shares of the company